PubRank

Shahid Husain

Author PubWeight™ 82.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008 9.05
2 Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007 2.31
3 Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002 2.09
4 Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2006 1.99
5 Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006 1.94
6 Antibiotic resistance: a survey of physician perceptions. Arch Intern Med 2002 1.91
7 Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007 1.78
8 Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect 2010 1.67
9 Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis 2009 1.60
10 Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl 2006 1.49
11 Fungal infections in solid organ transplantation. Med Mycol 2007 1.39
12 A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010 1.35
13 Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 2009 1.34
14 Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011 1.32
15 Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest 2007 1.32
16 Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003 1.27
17 Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis 2012 1.25
18 Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2006 1.23
19 Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004 1.21
20 Clinical evaluation of multiplex real-time PCR panels for rapid detection of respiratory viral infections. J Med Virol 2011 1.16
21 An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005 1.14
22 Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2006 1.12
23 Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2002 1.11
24 Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005 1.10
25 Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci 2010 1.10
26 Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol 2010 1.09
27 Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004 1.09
28 Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen. Antimicrob Agents Chemother 2006 1.06
29 Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 2005 1.05
30 Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates. Medicine (Baltimore) 2004 1.04
31 Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation 2005 1.02
32 Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007 1.00
33 Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007 0.98
34 LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant 2003 0.96
35 Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. J Ocul Pharmacol Ther 2003 0.96
36 Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008 0.95
37 Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol 2008 0.95
38 Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis 2010 0.94
39 A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol 2012 0.94
40 RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am J Physiol Regul Integr Comp Physiol 2003 0.92
41 Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation 2008 0.92
42 Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002 0.91
43 The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009 0.90
44 Evidence for multiple P2Y receptors in trabecular meshwork cells. J Pharmacol Exp Ther 2004 0.88
45 Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol 2006 0.87
46 Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. Antimicrob Agents Chemother 2006 0.85
47 Pharmacoeconomic assessment of therapy for invasive aspergillosis. Mycoses 2013 0.84
48 Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci 2013 0.83
49 Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010 0.83
50 Kinin modulation of conventional outflow facility in the bovine eye. J Ocul Pharmacol Ther 2006 0.83
51 Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation 2014 0.82
52 Assessment of infection risks prior to lung transplantation. Curr Opin Infect Dis 2010 0.82
53 Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. Exp Eye Res 2008 0.81
54 Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. Transpl Immunol 2006 0.80
55 Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study. Leuk Lymphoma 2012 0.80
56 Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. J Infect 2013 0.79
57 Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study. Transplantation 2011 0.79
58 Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation 2010 0.78
59 Mold infections in lung transplant recipients. Semin Respir Crit Care Med 2013 0.78
60 Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 2006 0.78
61 Community-acquired respiratory viral infections in lung transplant recipients. Curr Opin Infect Dis 2013 0.77
62 Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis. Curr Infect Dis Rep 2013 0.77
63 Delta-opioid receptors attenuate TNF-α-induced MMP-2 secretion from human ONH astrocytes. Invest Ophthalmol Vis Sci 2013 0.77
64 Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant 2010 0.76
65 Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008 0.76
66 Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation 2009 0.76
67 Peri-operative novel 2009 H1N1 influenza virus infection successfully treated with oseltamivir and zanamivir in a lung transplant recipient. J Heart Lung Transplant 2010 0.76
68 Fungal infections in lung transplant recipients. Curr Opin Pulm Med 2008 0.76
69 Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients. Transplantation 2017 0.76
70 Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle. Mol Vis 2013 0.75
71 The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant. Transplantation 2015 0.75
72 Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients. Clin Transplant 2013 0.75
73 Utility of a monitoring strategy for human herpesviruses 6 and 7 viremia after liver transplantation: a randomized clinical trial. Transplantation 2015 0.75
74 Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis 2006 0.75
75 FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys. Drug Dev Res 2014 0.75
76 Risk factors for late-onset cytomegalovirus infection or disease in kidney transplant recipients. Transplantation 2014 0.75
77 Small polaron hopping conduction mechanism in Fe doped LaMnO3. J Chem Phys 2011 0.75
78 Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis. Transpl Immunol 2013 0.75
79 Corrections to table. Arch Intern Med 2004 0.75